HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.

Abstract
A monoclonal antibody (MAb-HB55) directed against a HLA class II antigen (Ia), was purified by DE-52 chromatography. The purified MAb contained less than 5% impure protein detected by SDS-PAGE. Ricin was conjugated with the MAb via a disulfide bond to construct an immunotoxin (ricin-HB55). The concentration causing fifty percent growth inhibition (IC50) was 2 x 10(-11)M for the Raji cells. In contrast, the IC50 for Molt-4 and K562 cells was 100 times higher than that for the Raji cells. B lymphocytes separated from peripheral blood lymphocytes by nylon wool were selectively killed by the conjugate, but T lymphocytes were not apparently affected. Our results demonstrate that the immunotoxin is selectively cytotoxic to Raji cells and B-cells, and may have potential for purging malignant cells from bone marrow of patients with B-cell leukemia and lymphoma.
AuthorsM Wu, S L Tang, R J Zang, H Yu
JournalInternational journal of immunopharmacology (Int J Immunopharmacol) Vol. 12 Issue 2 Pg. 235-9 ( 1990) ISSN: 0192-0561 [Print] England
PMID2329015 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Histocompatibility Antigens Class II
  • Immunotoxins
  • Ammonium Chloride
  • Ricin
Topics
  • Ammonium Chloride (pharmacology)
  • Animals
  • Antibodies, Monoclonal (immunology, therapeutic use)
  • Antibody-Dependent Cell Cytotoxicity
  • B-Lymphocytes (drug effects)
  • Histocompatibility Antigens Class II (immunology)
  • Immunotoxins (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Ricin (pharmacology, therapeutic use)
  • T-Lymphocytes (drug effects)
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: